Minerals in the News
from The Mineral People™
Vol 4, Issue 10, October 2006

 

 

The influence of marginal zinc deficient diet on post-vaccination immune response against hepatitis B in rats.
Ozgenc F, et al.
Hepatol Res. 2006; 35(1):26-30


To evaluate in vitro T lymphocyte proliferation and specific antibody response to hepatitis B vaccination in two groups of rats fed with normal and marginal zinc content. Twenty-two Wistar-Albino rats were randomly assigned into two groups and were fed with constant diet. Zinc was supplemented 10mg/kg dry weight in group I (marginal zinc content) (n=14) and 30mg/kg dry weight in group II (n=8). Hepatitis B vaccine (Engerix B, 4mug) was administered intramuscularly after 8 weeks on feeding and a booster dose was applied 4 weeks after the first injection. Rats were killed 3 weeks after the second injection. Peripheral blood mononuclear cells were stimulated in vitro by PHA (2.5mug/ml) and hepatitis B surface antigen (2.5, 5, 10mug/ml). Proliferation was evaluated by ELISA (celltiter-96 aqueous one solution cell proliferation assay). Serum zinc, anti-HBs titer and zinc per dry liver weight were also measured. Two groups were compared with respect to antigen specific antibody and lymphocyte proliferation responses. Proliferation response to HbsAg were expressed as net percent increase (pci) in lymphocyte proliferation from the baseline activity. Rats' mean body weight and weight gain per month were similar. Median serum zinc was 39 (23-75) and 76(64-115)mug/dl of groups I and II rats, respectively (p<0.05), while there was no difference in liver zinc content between the two groups (37mug/g dry weight versus 32mug/g dry weight).
Median anti-HBs levels of groups I and II were 741 (0-10,000)IU/I, 5791 (558-10,000)IU/I, respectively (p<0.05). In lymphocyte proliferation assays, mean net pci with HbsAg of 5 and 10mug/ml were 9.4% and 11.3% in group I rats; while they were 25.3% and 26.1% in group II rats (p<0.01 and p<0.01, respectively). In vitro cell- mediated immune response and in vivo specific antibody response to hepatitis B vaccine was decreased in rats fed a diet with marginal zinc content.
These observations have shown that marginal Zn deficiency might influence the efficacy of hepatitis B vaccination in humans.


 

 

The effect of supplemental zinc on the height and weight percentiles of children
Hakimi SM, et al.
Arch Iran Med. 2006 Apr : 9(2) :148-52.


Considering the high incidence of low weight and short stature among Iranian children as well as the high prevalence of both mild and moderate types of zinc deficiency, this study was conducted among patients who were referred to the Pediatric Clinic at Massih Daneshvari Hospital during 1997 -1999. The aim of this study was to determine the effect of zinc supplementation on the children's height and weight percentiles. Age, sex, and height and weight percentiles before and after administration of zinc were determined and recorded. The zinc supplement used in this project was in the form of a zinc sulfate solution in 0.1 % and 0.5% concentrations. The dose was the upper limit of a tolerable dose, which was given in three divided doses per day. The serum zinc level was measured with the atomic absorption spectrophotometry method. The effect of age, sex, and initial serum zinc level on the percentile changes were determined. This study was conducted on 42 children with equal distribution of gender (21 male and 21 female patients). The mean age was 4.9 + / - 4.1 years. Means of height and weight were 101.8 + / - 23 cm and 16.5 +/ - 8.1 kg, respectively. The initial serum zinc level was 85.1 +/- 31.6 microg/ dL. The duration of zinc administration was 3.2 + /- 2.6 months. The subjects were followed for a minimum of one month to a maximum of 10 months. The percentage of children with weight and height percentiles below the 50th percentile was reduced from 69% to 54% (P < 0.05) and from 50% to 33% (P < 0.01), respectively. Also, it was noted that children with low serum zinc levels demonstrated greater percentile changes. It was concluded that supplemental zinc increases height and weight percentiles.

 

Zinc nutrition in healthy subjects and patients with taste impairment from the view point
of zinc ingestion, serum zinc concentration and angiotensin converting enzyme activity

Ueda C, et al.
Auris Nasus Larynx. 2006; 33(3):283-8
 

To estimate the zinc nutrition in healthy subjects and patients with taste impairment. Dietary zinc intake, zinc concentration in the serum and the ratio of apo/holo-activities of angiotensin converting enzyme (ACE), a zinc dependent enzyme in the serum (ACE ratio) were used as indices. Healthy paramedical volunteers from a local hospital were used as well as patients with taste impairment seen in the Department of Otolaryngology, Tokushima University Hospital. Dietary zinc intake was estimated with the food frequency questionnaire (FFQ). Zinc concentration in the serum was measured by means of atomic absorption spectrometry. The ACE activity in the serum was measured spectrophotometrically as the activity of holo-ACE, which contains zinc and shows full ACE activity. The activity of apo-ACE, which does not contain zinc, was determined as the increase of its activity over that of the initial holo-ACE activity after the addition of zinc to the serum in vitro. ACE ratio was used as a more sensitive indicator of zinc nutrition than measuring zinc concentration in the serum. The researchers found that there were no differences in dietary intake of zinc after adjusting for energy and zinc concentration in the serum between patients and age-adjusted healthy subjects. The ACE ratio in patients with taste impairment was significantly higher than that in age-adjusted healthy subjects (P<O.O5). The researchers data demonstrates that zinc deficiency is a predominant factor in underlying taste impairment and was hypothesized that patients with taste impairment may have malabsorption of dietary zinc.

 

Absorbability and utility of calcium in mineral waters
Robert P Heaney
Am J Clin Nutr 2006;84:371-4.
 

Calcium intake in North America remains substantially below recommended amounts. Bottled waters high in calcium could help close that gap. The objectives were to summarize and integrate published absorbability and biodynamic data concerning high-calcium mineral waters and to combine these data with unpublished analyses from a laboratory. The usual library database was searched. The absorbability of calcium from a high-mineral water labeled with tracer quantities of 45Ca was measured in human volunteers as a part of an otherwise low-calcium test meal. Published reports that used differing load sizes and meal conditions were harmonized by making corrections based on published calcium absorbability data. All the high-calcium mineral waters had absorbabilities equal to milk calcium or slightly better. When tested, all produced biodynamic responses indicative of absorption of appreciable quantities of calcium (ie, increased urinary calcium, decreased serum parathyroid hormone, decreased bone resorption biomarkers, and protection of bone mass). Dr. Heaney concluded that high-calcium mineral waters could provide useful quantities of bioavailable calcium.

 

Magnesium and muscle performance in older persons: the InCHIANTI study
Dominquez LJ, et al.
Am J Clin Nutr 2006;84:419-26.
 

The role of magnesium in maintaining muscle integrity and function in older adults is largely unknown. The researchers investigated the relation between serum magnesium concentrations and muscle performance in older subjects. The data are from the baseline examination conducted between September 1998 and March 2000 of the InCHIANTI (aging in the Chianti area) study, a prospective epidemiologic survey of risk factors for late-life disability. From among 1453 randomly selected community residents completing a home interview, 1138 men (46%) and women (aged 66.7 +/- 15.2 y; average +/- SD) with complete data on muscle performance and serum magnesium who were not severely cognitively compromised and had no evidence of kidney disease or hypercalcemia were included in the analysis. Muscle performance was evaluated by grip strength, lower-leg muscle power, knee extension torque, and ankle extension isometric strength and was normalized for age and body mass index (BMI) within each sex. After adjustment for age, sex, BMI, laboratory variables, presence of chronic diseases, muscle area, muscle density, and physical activity level, serum magnesium concentrations were significantly associated with indexes of muscle performance, including grip strength (β = 2.0 +/- 0.5, P = 0.0002), lowerleg muscle power (β = 8.8 +/- 2.7, P = 0.001), knee extension torque (β = 31.2 +/- 7.9, P<0.0001), and ankle extension strength (β = 3.8 +/- 0.5, P<0.0001). It was concluded that the serum magnesium concentration is an independent correlate of muscle performance in older persons. Whether magnesium supplementation improves muscle function remains to be shown.